The minimal inhibitory concentration for sulbactam was not associated with the outcome of infections caused by carbapenem-resistant Acinetobacter sp. treated with ampicillin/sulbactam

The minimal inhibitory concentration for sulbactam was not associated with the outcome of infections caused by carbapenem-resistant Acinetobacter sp. treated with ampicillin/sulbactam

Bibliographic Details
Main Authors:	de Oliveira, Maura S., Costa, Silvia Figueiredo, de Pedri, Ewerton, van der Heijden, Inneke, Levin, Anna Sara S.
Format:	Online
Language:	English
Published:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634950/

Similar Items

AMPICILLIN SULBACTAM AND CEFOTAXIME ARE SIMILARLY EFFECTIVE IN PEDIATRIC PNEUMONIA
by: Diny Puspitasari, et al.
Published: (2017-08-01)

AMPICILLIN SULBACTAM RESISTANCE PATTERN AS A FIRST-LINE DRUG IN CHILDREN
by: Oka Putrawan, et al.
Published: (2016-11-01)

Contribution of Acinetobacter-derived cephalosporinase-30 to sulbactam resistance in Acinetobacter baumannii
by: Kuo, Shu-Chen, et al.
Published: (2015)

Synergistic effects of sulbactam in multi-drug-resistant Acinetobacter baumannii
by: Temocin, Fatih, et al.
Published: (2015)

Hypersensitivity vasculitis induced by cefoperazone/sulbactam
by: Islek, Ismail, et al.
Published: (2003)

A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections
by: Xin, Xiaojuan, et al.
Published: (2013)

T.E.A. Study: three-day ertapenem versus three-day Ampicillin-Sulbactam
by: Catena, Fausto, et al.
Published: (2013)

A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections
by: Matthews, Peter, et al.
Published: (2012)

Role of ampicillin-sulbactam: a district hospital's experience in treating diabetic foot ulcers
by: Nurul Nadiah Zainal Abidin
Published: (2012)

Lower Body Mass Index is a Risk Factor for In-Hospital Mortality of Elderly Japanese Patients Treated with Ampicillin/sulbactam
by: Miura, Makoto, et al.
Published: (2016)

Sulbactam-enhanced cytotoxicity of doxorubicin in breast cancer cells
by: Shao-hsuan Wen, et al.
Published: (2018-09-01)

Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex
by: Ye, Jung-Jr, et al.
Published: (2016)

A prospective, multi centre, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin - Sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection. (T.E.A. Study: Three days Ertapenem vs three days Ampicillin-sulbactam)
by: Coccolini, Federico, et al.
Published: (2011)

Incidence of postpartum endomyometritis following single-dose antibiotic prophylaxis with either ampicillin/sulbactam, cefazolin, or cefotetan in high-risk cesarean section patients.
by: Noyes, N, et al.
Published: (1998)

Appropriate composites of cefoperazone–sulbactam against multidrug-resistant organisms
by: Lai CC, et al.
Published: (2018-09-01)

The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms
by: Ping-Chin Chang, et al.
Published: (2018-04-01)

Acute localized exanthematous pustulosis caused by cefoperazone and sodium sulbactam*
by: Qu, Yan-Jing, et al.
Published: (2016)

Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins
by: van der Heijden, Inneke M, et al.
Published: (2007)

Comparison in a rat thigh abscess model of imipenem, meropenem and cefoperazone-sulbactam against Acinetobacter baumannii strains in terms of bactericidal efficacy and resistance selection
by: Fetiye, Kolayli, et al.
Published: (2004)

Drug concentrations in the serum and cerebrospinal fluid of patients treated with cefoperazone/sulbactam after craniotomy
by: Wang, Qiang, et al.
Published: (2015)

A Novel High Performance Liquid Chromatographic Method for Simultaneous Determination of Ceftriaxone and Sulbactam in Sulbactomax
by: Shrivastava, Sanjay Mohan, et al.
Published: (2009)

Imipenem-Cilastatin versus Sulbactam-Cefoperazone plus Amikacin in the Initial Treatment of Febrile Neutropenic Cancer Patients
by: ÖZYILKAN, Özgür, et al.
Published: (1999)

Cefoperazone/Sulbactam-Induced Abdominal Wall Hematoma and Upper Gastrointestinal Bleeding: A Case Report and Review of the Literature
by: Cai, ZhuYing, et al.
Published: (2016)

Colonization pressure as a risk factor for colonization by multiresistant Acinetobacter spp and carbapenem-resistant Pseudomonas aeruginosa in an intensive care unit
by: DalBen, Mirian Freitas, et al.
Published: (2013)

Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model
by: Fan, Bing, et al.
Published: (2016)

Protective role of ceftriaxone plus sulbactam with VRP1034 on oxidative stress, hematological and enzymatic parameters in cadmium toxicity induced rat model
by: Dwivedi, Vivek Kumar, et al.
Published: (2012)

Comparison of commonly used antimicrobial susceptibility testing methods for evaluating susceptibilities of clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli to cefoperazone–sulbactam
by: Shio-Shin Jean, et al.
Published: (2017-08-01)

Sulbactam Protects Hippocampal Neurons Against Oxygen-Glucose Deprivation by Up-Regulating Astrocytic GLT-1 via p38 MAPK Signal Pathway
by: Jie Qi, et al.
Published: (2018-08-01)

Tracking Cefoperazone/Sulbactam Resistance Development In vivo in A. baumannii Isolated from a Patient with Hospital-Acquired Pneumonia by Whole-Genome Sequencing
by: Liu, Xiaofen, et al.
Published: (2016)

Increase in the Prevalence of Carbapenem-Resistant Acinetobacter Isolates and Ampicillin-Resistant Non-Typhoidal Salmonella Species in Korea: A KONSAR Study Conducted in 2011
by: Yong, Dongeun, et al.
Published: (2014)

Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis
by: Yang, Ya-Sung, et al.
Published: (2013)

Carbapenem-resistant Acinetobacter baumannii outbreak at university hospital
by: Takagi, E.H., et al.
Published: (2009)

Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii
by: Tiwari, Vishvanath, et al.
Published: (2014)

Effects of Group 1 versus Group 2 Carbapenems on the Susceptibility of Acinetobacter baumannii to Carbapenems: A Before and After Intervention Study of Carbapenem-Use Stewardship
by: Yoon, Young Kyung, et al.
Published: (2014)

Effectiveness of Ampicillin and Ampicillin-Gentamicin for Children under Five Years Old with Pneumonia
by: Salma H. California, et al.
Published: (2018-03-01)

Corrigendum to “Comparison of commonly used antimicrobial susceptibility testing methods for evaluating susceptibilities of clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli to cefoperazone-sulbactam” [J Microbiol Immunol Infect (2017) 50: 454–463]
by: Shio-Shin Jean, et al.
Published: (2018-04-01)

Interaction of imipenem and tigecycline against carbapenem-resistant acinetobacter baumanii: the relativity of synergism
by: Alfizah, H., et al.
Published: (2015)

Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii
by: Vashist, Jitendra, et al.
Published: (2011)

Carbapenem-resistant Acinetobacter ventilator-associated pneumonia: Clinical characteristics and outcome
by: Gurjar, Mohan, et al.
Published: (2013)

Effects of Carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients
by: Ogutlu, Aziz, et al.
Published: (2014)